PATENT CLAIM ANALYSIS

Application Number: 15780051
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "182000"]

Abstract:
The present invention relates to a pharmaceutical composition for radioprotection or radiomitigation with respect to radiation-induced damage, the composition comprising a compound of Formula 1, or a pharmaceutically acceptable salt thereof or a solvate thereof.

Claim (Index 15):
The method of  claim 9 , wherein the radiation-induced damage is caused by radiation exposure, and the compound of Formula 1, the pharmaceutically acceptable salt thereof, or the solvate thereof is administered before or after the radiation exposure.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 93.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15852977', '11958353', '12287664', '13813923', '13084408']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7614060028930981
- 35 USC 102 Novelty (BERT): 0.5019231364208331
- Combined Prediction Score: 0.7354577162458716
- Mean Citation Score: 195.415314
- Max Citation Score: 204.52432
- Similarity Product: 128.57561765693666

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test